α-Synuclein impairs ferritinophagy in the retinal pigment epithelium: Implications for retinal iron dyshomeostasis in Parkinson’s disease

[1]  T. Postmus.  Genetics of Parkinson's disease , 2018 .

[2]  F. Cecconi,et al.  Autophagy and the Cell Cycle: A Complex Landscape , 2017, Front. Oncol..

[3]  M. Goedert,et al.  Like prions: the propagation of aggregated tau and &agr;-synuclein in neurodegeneration , 2017, Brain : a journal of neurology.

[4]  D. di Lorenzo,et al.  Iron and Neurodegeneration: Is Ferritinophagy the Link? , 2015, Molecular Neurobiology.

[5]  Neena Singh,et al.  Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease. , 2016, Free radical biology & medicine.

[6]  Lindsay Perusek,et al.  Autophagy in light-induced retinal damage. , 2016, Experimental eye research.

[7]  D. Krainc,et al.  α-Synuclein–induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models , 2016, Proceedings of the National Academy of Sciences.

[8]  M. Xilouri,et al.  Autophagy and Alpha‐Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies , 2016, Movement disorders : official journal of the Movement Disorder Society.

[9]  N. Andrews,et al.  Lethal Cardiomyopathy in Mice Lacking Transferrin Receptor in the Heart. , 2015, Cell reports.

[10]  P. Brundin,et al.  Acceleration of α-Synuclein Aggregation by Exosomes* , 2014, The Journal of Biological Chemistry.

[11]  John A. Tallarico,et al.  Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo , 2014, Nature Cell Biology.

[12]  Neena Singh,et al.  Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease. , 2014, Antioxidants & redox signaling.

[13]  DuhamelAlain,et al.  Targeting chelatable iron as a therapeutic modality in Parkinson's disease. , 2014 .

[14]  C. Mitchell,et al.  Autophagy in the eye: implications for ocular cell health. , 2014, Experimental eye research.

[15]  Ivan Bodis-Wollner,et al.  α‐synuclein in the inner retina in parkinson disease , 2014, Annals of neurology.

[16]  E. Popova.  Role of dopamine in distal retina , 2014, Journal of Comparative Physiology A.

[17]  S. Gygi,et al.  Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy , 2014, Nature.

[18]  A. Mukhopadhyay,et al.  Rab1a regulates sorting of early endocytic vesicles. , 2014, American journal of physiology. Gastrointestinal and liver physiology.

[19]  Walter Stark,et al.  Beta‐Amyloid, Phospho‐Tau and Alpha‐Synuclein Deposits Similar to Those in the Brain Are Not Identified in the Eyes of Alzheimer's and Parkinson's Disease Patients , 2014, Brain pathology.

[20]  N. Osborne,et al.  Iron, zinc, and copper in retinal physiology and disease. , 2013, Survey of ophthalmology.

[21]  L. Liotta,et al.  Retinal pigment epithelium (RPE) exosomes contain signaling phosphoproteins affected by oxidative stress. , 2013, Experimental cell research.

[22]  F. Loreni,et al.  &agr;-Synuclein expression is modulated at the translational level by iron , 2012, Neuroreport.

[23]  Peter Riederer,et al.  The relevance of iron in the pathogenesis of Parkinson’s disease , 2011, Journal of neurochemistry.

[24]  Ying Sun,et al.  Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies , 2011, Cell.

[25]  U. Mosimann,et al.  Retinal thickness in Parkinson's disease. , 2011, Parkinsonism & related disorders.

[26]  Chris Gardiner,et al.  Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission , 2011, Neurobiology of Disease.

[27]  R. Armstrong,et al.  Visual Symptoms in Parkinson's Disease , 2011, Parkinson's disease.

[28]  F. Ishikawa,et al.  Distinct Mechanisms of Ferritin Delivery to Lysosomes in Iron-Depleted and Iron-Replete Cells , 2011, Molecular and Cellular Biology.

[29]  Philip L De Jager,et al.  Parkinson's disease: genetics and pathogenesis. , 2011, Annual review of pathology.

[30]  Steve D. M. Brown,et al.  α-Synuclein impairs macroautophagy: implications for Parkinson’s disease , 2010, The Journal of cell biology.

[31]  J. T. Greenamyre,et al.  Mitochondrial iron metabolism and its role in neurodegeneration. , 2010, Journal of Alzheimer's disease : JAD.

[32]  K. Palczewski,et al.  Phagocytosis of retinal rod and cone photoreceptors. , 2010, Physiology.

[33]  M. Tso,et al.  Autophagy, exosomes and drusen formation in age-related macular degeneration , 2009, Autophagy.

[34]  Urs P Mosimann,et al.  The retina in Parkinson's disease. , 2009, Brain : a journal of neurology.

[35]  Neena Singh,et al.  Abnormal Brain Iron Homeostasis in Human and Animal Prion Disorders , 2009, PLoS pathogens.

[36]  M. Mohan,et al.  Prion Protein Modulates Cellular Iron Uptake: A Novel Function with Implications for Prion Disease Pathogenesis , 2009, PloS one.

[37]  M. Cookson.  α-Synuclein and neuronal cell death , 2009, Molecular Neurodegeneration.

[38]  D. Selkoe,et al.  α‐Synuclein and Polyunsaturated Fatty Acids Promote Clathrin‐Mediated Endocytosis and Synaptic Vesicle Recycling , 2009, Traffic.

[39]  J. Debnath,et al.  PLIC proteins or ubiquilins regulate autophagy‐dependent cell survival during nutrient starvation , 2009, EMBO reports.

[40]  Charles Duyckaerts,et al.  Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease , 2008, Proceedings of the National Academy of Sciences.

[41]  Martyn N J Paley,et al.  MRI assessment of basal ganglia iron deposition in Parkinson's disease , 2008, Journal of magnetic resonance imaging : JMRI.

[42]  S. Lindquist,et al.  The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis , 2008, Proceedings of the National Academy of Sciences.

[43]  G. Martínez-Navarrete,et al.  α-Synuclein gene expression profile in the retina of vertebrates , 2007, Molecular Vision.

[44]  M. Elstner,et al.  Individual dopaminergic neurons show raised iron levels in Parkinson disease , 2007, Neurology.

[45]  M. Linder,et al.  Release of iron from ferritin requires lysosomal activity. , 2006, American journal of physiology. Cell physiology.

[46]  S. Lindquist,et al.  α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.

[47]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[48]  E. Hirsch,et al.  Lack of up‐regulation of ferritin is associated with sustained iron regulatory protein‐1 binding activity in the substantia nigra of patients with Parkinson's disease , 2002, Journal of neurochemistry.

[49]  M. Frasier,et al.  Magnesium Inhibits Spontaneous and Iron-induced Aggregation of α-Synuclein* , 2002, The Journal of Biological Chemistry.

[50]  M. Linder,et al.  Iron Prevents Ferritin Turnover in Hepatic Cells* , 2001, The Journal of Biological Chemistry.

[51]  D. Radisky,et al.  Iron in cytosolic ferritin can be recycled through lysosomal degradation in human fibroblasts. , 1998, The Biochemical journal.

[52]  R. Pagano,et al.  Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[53]  D. Richardson,et al.  The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone. , 1997, Blood.

[54]  D. Greene,et al.  Sorbitol, myo-Inositol, and Rod Outer Segment Phagocytosis in Cultured hRPE Cells Exposed to Glucose: In Vitro Model of myo-Inositol Depletion Hypothesis of Diabetic Complications , 1991, Diabetes.

[55]  R. Pagano,et al.  Sorting of an internalized plasma membrane lipid between recycling and degradative pathways in normal and Niemann-Pick, type A fibroblasts , 1990, The Journal of cell biology.

[56]  D. Rubinsztein,et al.  LC3-II Tagging and Western Blotting for Monitoring Autophagic Activity in Mammalian Cells. , 2016, Methods in molecular biology.

[57]  L. Defebvre,et al.  Targeting Chelatable Iron as a Therapeutic Modality in Parkinson ’ s Disease , 2016 .

[58]  S. Lindquist,et al.  The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. , 2008, Proceedings of the National Academy of Sciences of the United States of America.

[59]  M. Frasier,et al.  Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein. , 2002, The Journal of biological chemistry.

[60]  David A. Lewis,et al.  Implications for Parkinson ' s Disease , 2022 .